Search results for "Diabetes"


 
Results 91 - 100 of about 963 for "Diabetes".
Sort by: Relevance | Newest | Oldest

The ins and outs of insulin updates, new guidelines, and more

This month's issue addresses insulin, an updated cardiology guideline, and colorectal cancer screening.
https://immattersacp.org/archives/2024/02/the-ins-and-outs-of-insulin-updates-new-guidelines-and-more.htm
1 Feb 2024

Marking achievements in gender equity

The President-elect of the American Medical Women's Association discusses mentorship, advocacy, and more.
https://immattersacp.org/archives/2023/09/marking-achievements-in-gender-equity.htm
1 Sep 2023

Lower systolic blood pressure target appears to improve outcomes in elderly patients without diabetes or stroke

Treating to lower systolic blood pressure targets in ambulatory adults ages 75 years and older led to better outcomes, specifically lower rates of all-cause mortality and cardiovascular events.
https://immattersacp.org/weekly/archives/2016/05/24/1.htm
24 May 2016

Choice of third oral diabetes drug can depend on each patient's needs

There is no clear choice for a third oral agent for controlling A1c levels above 7% following metformin and a sulfonylurea, researchers concluded from a meta-analysis of type 2 diabetics, so the best choice depends on the patient's need.
https://immattersacp.org/weekly/archives/2011/05/17/1.htm
17 May 2011

Is self-monitoring of blood glucose still needed for diabetes?

Self-monitoring of blood glucose could become more of a targeted therapy than a blanket approach, with individual factors determining its value, experts say.
https://immattersacp.org/archives/2017/10/is-self-monitoring-of-blood-glucose-still-needed-for-diabetes.htm
1 Oct 2017

Nearly 50% of older U.S. adults reported taking aspirin preventively

A study of National Health and Nutrition Examination Survey data from 2011 to 2018 found that 46.7% of respondents ages 60 years and older used aspirin for primary or secondary cardiovascular disease prevention and suggested potential overuse in certain groups.
https://immattersacp.org/weekly/archives/2021/06/29/4.htm
29 Jun 2021

MKSAP Quiz: Episodic nausea, bloating, epigastric pain

A 45-year-old woman is evaluated for episodic nausea, bloating, and epigastric pain of 5 years' duration, with occasional vomiting in the past 3 months, as well as near-daily heartburn symptoms that have not responded to daily omeprazole. She has a 10-year history of type 2 diabetes mellitus treated with metformin and glyburide. After physical exam, laboratory tests, and upper endoscopy, what is the next appropriate step in management?
https://immattersacp.org/weekly/archives/2021/01/12/4.htm
12 Jan 2021

Regular use of PPIs linked to increased risk of type 2 diabetes

In an analysis of the Nurses' Health and Health Professionals studies, regular users of proton-pump inhibitors (PPIs) had a 24% higher risk of diabetes than nonusers, with longer duration of use associated with greater risk.
https://immattersacp.org/weekly/archives/2020/10/06/6.htm
6 Oct 2020

Hydrochlorothiazide no better than placebo for preventing kidney stone recurrence

A randomized, double-blind, placebo-controlled trial in Switzerland found that patients with a history of recurring kidney stones were no less likely to experience symptomatic or radiologic recurrence with hydrochlorothiazide versus placebo.
https://immattersacp.org/weekly/archives/2023/03/07/1.htm
7 Mar 2023

Dapagliflozin associated with improved outcomes for HF with mildly reduced or preserved ejection fraction

An industry-funded study found patients with heart failure (HF) and an ejection fraction above 40% had a lower combined risk for worsening HF or cardiovascular death if they were randomly assigned to receive dapagliflozin versus placebo.
https://immattersacp.org/weekly/archives/2022/08/30/5.htm
30 Aug 2022

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next